Medifacts International Announces Appointment of Michael E. Woehler as Chief Executive Officer


Applied Clinical Trials

CEO transition positions Medifacts for growth and expansion

ROCKVILLE, MARYLAND (USA) / LANGENFELD, GERMANY– October 31, 2006 – Medifacts International, a global provider of clinical research and cardiac safety services, announced today that Michael E. Woehler, PhD has been named as the Company's new President and Chief Executive Officer.

Dr. Woehler has had more than 25 years of experience in leading global businesses in the life sciences and CRO industries. Most recently, he served as the Executive Vice President of PAREXEL International Corporation where he was responsible for the Worldwide Consulting, Medical Marketing Services and Clinical Pharmacology business, Corporate Services, and the Corporate Quality divisions. Dr. Woehler also served as PAREXEL's Senior Vice President and President of Clinical Research Services for four years where he managed 3000 employees worldwide.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.